AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

New research suggests that a larger waist circumference is a bigger risk factor than body mass index (BMI) for ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

When it comes to any supplement, the best way to gauge its real effectiveness is to look at user reviews and consumer ...

Users who stick with Mitolyn for at least 3 to 4 weeks report smoother digestion, sustained energy, and a more balanced metabolic rhythm. This aligns with expert insights on mitochondrial function- as ...

it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can cause cancer of the thyroid. Six months ago, the Pharmacovigilance Risk ...

This coming Advent, Catholics throughout the English-speaking world will begin using a new translation for the prayers that we say in the Mass. This new, third edition of the Roman Missal is the ...

Type 1 diabetes is an autoimmune condition associated with genetics and may develop suddenly. Type 2 diabetes often develops over time, with obesity and a lack of exercise as the main risk factors.

So, sometime next year you’re attending Sunday Mass as you always do, the priest takes his place in the sanctuary, makes the Sign of the Cross and says “The Lord be with you,” and you ...